Bayesian Capital Management’s INPHI CORPORATION IPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,464
Closed -$440K 726
2021
Q1
$440K Buy
2,464
+100
+4% +$16.7K 0.1% 254
2020
Q4
$379K Sell
2,364
-8,794
-79% -$1.24M 0.1% 262
2020
Q3
$1.25M Sell
11,158
-7,600
-41% -$887K 0.31% 79
2020
Q2
$2.2M Sell
18,758
-300
-2% -$31.6K 0.49% 37
2020
Q1
$1.51M Buy
19,058
+11,058
+138% +$859K 0.33% 63
2019
Q4
$592K Sell
8,000
-2,000
-20% -$137K 0.1% 275
2019
Q3
$610K Buy
10,000
+3,010
+43% +$183K 0.12% 236
2019
Q2
$350K Buy
+6,990
New +$325K 0.07% 334
2017
Q1
Sell
-12,800
Closed -$571K 769
2016
Q4
$571K Buy
12,800
+6,816
+114% +$293K 0.14% 271
2016
Q3
$260K Buy
+5,984
New +$231K 0.17% 229

Bayesian Capital Management's IPHI Position: Q2 2021 in Review

Bayesian Capital Management sold out of INPHI CORPORATION (IPHI) in Q2 2021, closing a stake of 2,464 shares — an estimated $440K sold.

Bayesian Capital Management first reported a position in IPHI in Q3 2016 and held it in 10 quarters. The position peaked at $2.2M in Q2 2020. 1 fund tracked by Wall St. Rank holds IPHI as of Q2 2021.

  • Bayesian Capital Management reported no remaining INPHI CORPORATION position as of Q2 2021 after selling out during the quarter.
  • Bayesian Capital Management sold 2,464 INPHI CORPORATION shares in Q2 2021, an estimated $440K.
  • Bayesian Capital Management first reported a position in INPHI CORPORATION in Q3 2016 and held it in 10 quarters.
  • Bayesian Capital Management's INPHI CORPORATION position peaked at $2.2M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held INPHI CORPORATION as of Q2 2021.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.